DRTS – alpha tau medical ltd. - ordinary shares (US:NASDAQ)

News

Alpha Tau Medical (DRTS) had its price target raised by Citigroup Inc. from $7.00 to $9.00. They now have a "buy" rating on the stock.
Alpha Tau Medical (DRTS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.
Alpha Tau Medical GAAP EPS of -$0.42 [Seeking Alpha]
Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com